湖南师范大学学报(医学版)
湖南師範大學學報(醫學版)
호남사범대학학보(의학판)
Journal of Hunan Normal University (Medical Science)
2015年
5期
96-97,98
,共3页
顾娟%张春访%张建林%陈相
顧娟%張春訪%張建林%陳相
고연%장춘방%장건림%진상
中段尿%细菌%分布%耐药性
中段尿%細菌%分佈%耐藥性
중단뇨%세균%분포%내약성
medistream urine%bacteria%distribution%drug resistance
目的:了解140例患者中段尿培养检出细菌的分布及耐药情况。方法:对患者中段尿液阳性标本,采用半自动细菌鉴定分析仪及药敏分析仪进行鉴定和药敏分析。结果:(1)中段尿培养检出病原菌以革兰氏阴性菌为主,占58.6%。(2)革兰氏阴性菌中,大肠埃希菌对青霉素、头孢呋辛、头孢噻肟及左氧氟沙星的耐药率均较高;肺炎克雷伯菌对头孢噻肟的耐药率较高;铜绿假单胞菌对头孢呋辛、头孢噻肟和复方新诺明的耐药率均达到100.0%。(3)革兰氏阳性菌中,葡萄球菌属对青霉素和头孢噻肟的耐药率较高;肠球菌属对庆大霉素、阿米卡星和红霉素的耐药率均达到100.0%。结论:临床上应加强对中段尿检测,病原菌对抗菌药物存在多药耐药性,指导临床合理用药,降低耐药率。
目的:瞭解140例患者中段尿培養檢齣細菌的分佈及耐藥情況。方法:對患者中段尿液暘性標本,採用半自動細菌鑒定分析儀及藥敏分析儀進行鑒定和藥敏分析。結果:(1)中段尿培養檢齣病原菌以革蘭氏陰性菌為主,佔58.6%。(2)革蘭氏陰性菌中,大腸埃希菌對青黴素、頭孢呋辛、頭孢噻肟及左氧氟沙星的耐藥率均較高;肺炎剋雷伯菌對頭孢噻肟的耐藥率較高;銅綠假單胞菌對頭孢呋辛、頭孢噻肟和複方新諾明的耐藥率均達到100.0%。(3)革蘭氏暘性菌中,葡萄毬菌屬對青黴素和頭孢噻肟的耐藥率較高;腸毬菌屬對慶大黴素、阿米卡星和紅黴素的耐藥率均達到100.0%。結論:臨床上應加彊對中段尿檢測,病原菌對抗菌藥物存在多藥耐藥性,指導臨床閤理用藥,降低耐藥率。
목적:료해140례환자중단뇨배양검출세균적분포급내약정황。방법:대환자중단뇨액양성표본,채용반자동세균감정분석의급약민분석의진행감정화약민분석。결과:(1)중단뇨배양검출병원균이혁란씨음성균위주,점58.6%。(2)혁란씨음성균중,대장애희균대청매소、두포부신、두포새우급좌양불사성적내약솔균교고;폐염극뢰백균대두포새우적내약솔교고;동록가단포균대두포부신、두포새우화복방신낙명적내약솔균체도100.0%。(3)혁란씨양성균중,포도구균속대청매소화두포새우적내약솔교고;장구균속대경대매소、아미잡성화홍매소적내약솔균체도100.0%。결론:림상상응가강대중단뇨검측,병원균대항균약물존재다약내약성,지도림상합리용약,강저내약솔。
ObjectiveTo investigate the bacteria distribution and drug resistance in patients with medistream urine.Meth-ods 140 patients with medistream urine were identified and determined by Semi-automatic system and susceptibility analyzers. Results(1) Gram-negative bacteria occupied 58.6% in medistream urine. (2) The rate of drug resistance of Escherichia coli to penicillin, cefuroxime, cefotaxime and levofloxacin was higher, respectively. The rate of drug resistance of Klebsiella pneumo-niae to cefotaxime was higher. The rate of drug resistance of Pseudomonas aeruginosa to cefuroxime, cefotaxime and cotrimoxa-zole was 100%. (3) The rate of drug resistance of Staphylococcus to penicilin, and cefotaxime was higher, respectively. The rate of drug resistance of Enterococcus to gentamicin, amikacin and erythromycin was 100%, respectively.Conclusion Pathogenic bacteria are always multidrug-resistant, it is necessary to focus on the etiology examination and the rational use of antibiotics so as to reduce the drug resistance rate.